title: Should cancer patients with incurable disease receive parenteral or enteral nutritional support?
authors.affiliation: University Department of Surgery, Royal Infirmary of Edinburgh, U.K.
authors.forename: M D
authors.initials: MD
authors.lastname: Barber
authors.forename: K C
authors.initials: KC
authors.lastname: Fearon
authors.forename: G
authors.initials: G
authors.lastname: Delmore
authors.forename: C L
authors.initials: CL
authors.lastname: Loprinzi
mesh_terms: D001120:Arginine / Q000008:administration & dosage; D003657:Decision Making; D004750:Enteral Nutrition; D015525:Fatty Acids, Omega-3 / Q000008:administration & dosage; D005973:Glutamine / Q000008:administration & dosage; D006801:Humans; D009369:Neoplasms / Q000628:therapy*; D010288:Parenteral Nutrition; D011379:Prognosis; D011788:Quality of Life; D013727:Terminal Care / Q000379:methods*
chemical_list: D015525:Fatty Acids, Omega-3; D005973:Glutamine; D001120:Arginine